{"organizations": [], "uuid": "5a54da8338cdf239829a05f5627a5e27c045f346", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-approves-pdufa-fee-waiver-for/brief-fda-approves-pdufa-fee-waiver-for-gimoti-new-drug-application-idUSASB0C8Q9", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.253, "site_type": "news", "published": "2018-03-05T20:41:00.000+02:00", "replies_count": 0, "uuid": "5a54da8338cdf239829a05f5627a5e27c045f346"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-approves-pdufa-fee-waiver-for/brief-fda-approves-pdufa-fee-waiver-for-gimoti-new-drug-application-idUSASB0C8Q9", "ord_in_thread": 0, "title": "BRIEF-FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "pdufa", "sentiment": "negative"}, {"name": "reuters) - evoke pharma inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - Evoke Pharma Inc:\n* FDA APPROVES PDUFA FEE WAIVER FOR GIMOTIâ„¢ NEW DRUG APPLICATION\n* FDA GRANTED ITS REQUEST FOR SMALL BUSINESS WAIVER OF PDUFA FEE OF ABOUT $2.4 MILLION FOR ITS TREATMENT GIMOTI\n* COMPANY REMAINS ON TRACK TO FILE GIMOTI NDA NEXT QUARTER * LOOK FORWARD TO POTENTIAL U.S. PRODUCT LAUNCH IN 2019 OF GIMOTI\n* AS CO REVIEWS 2018 BUDGET, ABLE TO EXTEND CASH RUNWAY INTO OCTOBER 2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-05T20:41:00.000+02:00", "crawled": "2018-03-06T22:22:21.001+02:00", "highlightTitle": ""}